title: Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.
abstract: It is generally accepted that human cancers derive from a mutated single cell. However, the genetic steps characterizing various stages of progression remain unclear. Studying a unique case of metastatic melanoma, we observed that cell lines derived from metachronous metastases arising over a decade retained a central core of genetic stability in spite of divergent phenotypes. In the present study, we expanded our previous observations comparing these autologous cell lines of clonal derivation with allogeneic ones and correlated array comparative genomic hybridization (aCGH) with gene expression profiling to determine their relative contribution to the dynamics of disease progression. aCGH and gene expression profiling were performed on autologous cell lines and allogeneic melanoma cell lines originating from other patients. A striking correlation existed between total extent of genetic imbalances, global transcriptional patterns, and cellular phenotypes. They did not follow a strict temporal progression but stemmed independently at various time points from a central core of genetic stability best explained according to the cancer stem cell hypothesis. Although their contribution was intertwined, genomic imbalances detectable by aCGH contributed only 25% of the transcriptional traits determining autologous tumor distinctiveness. Our study provides important insights about the dynamics of cancer progression and supports the development of targeted anticancer therapies aimed against stable genetic factors that are maintained throughout the end stage of disease.
authors.affiliation: Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, Biometrics Research Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892-1184, USA.
authors.forename: Marianna
authors.initials: M
authors.lastname: Sabatino
authors.forename: Yingdong
authors.initials: Y
authors.lastname: Zhao
authors.forename: Sonia
authors.initials: S
authors.lastname: Voiculescu
authors.forename: Alessandro
authors.initials: A
authors.lastname: Monaco
authors.forename: Paul
authors.initials: P
authors.lastname: Robbins
authors.forename: Laszlo
authors.initials: L
authors.lastname: Karai
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Nickoloff
authors.forename: Michele
authors.initials: M
authors.lastname: Maio
authors.forename: Silvia
authors.initials: S
authors.lastname: Selleri
authors.forename: Francesco M
authors.initials: FM
authors.lastname: Marincola
authors.forename: Ena
authors.initials: E
authors.lastname: Wang
mesh_terms: D001483:Base Sequence; D045744:Cell Line, Tumor; D043171:Chromosomal Instability; D002877:Chromosomes, Human / Q000235:genetics; D017124:Conserved Sequence; D004273:DNA, Neoplasm / Q000032:analysis / Q000235:genetics*; D005260:Female; D020869:Gene Expression Profiling; D006801:Humans; D008297:Male; D008545:Melanoma / Q000235:genetics* / Q000556:secondary; D008969:Molecular Sequence Data; D014411:Neoplastic Stem Cells / Q000378:metabolism* / Q000473:pathology; D009693:Nucleic Acid Hybridization; D012008:Recurrence; D012878:Skin Neoplasms / Q000235:genetics* / Q000473:pathology
chemical_list: D004273:DNA, Neoplasm